CATALYST is a collaborative phase II adaptive platform trial set up in response to the Coronavirus Disease 2019 (COVID-19) pandemic. We work with intensive care, respiratory and inflammatory researchers across the UK to rapidly trial new treatments for UK patients hospitalised with severe COVID-19.